Return to Article Details
COMPARISON OF EFFICACY AND SAFETY PROFILE OF EMPAGLIFLOZIN VERSUS DAPAGLIFLOZIN AS ADD ON THERAPY IN TYPE 2 DIABETIC PATIENTS
Download
Download PDF